Position in IMNM
as of Dec 31, 2025
· filed Feb 17, 2026
Position Value
$214,800
New position
Shares Held
10,000
first reported quarter
Ownership
0.009%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Dec 31, 2025Sandia Investment Management LP holds $1,593,938 across 7 Biotechnology names. IMNM ranks #3 (13.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CAI |
Caris Life Sciences, Inc.
|
23,600 | $636,728 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
5,000 | $398,250 | |
| 3 | IMNM |
Immunome Inc.
This page
|
10,000 | $214,800 | |
| 4 | RAPP |
Rapport Therapeutics, Inc.
|
6,000 | $182,040 | |
| 5 | VERA |
Vera Therapeutics, Inc.
|
2,500 | $126,600 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
1,000 | $35,520 | |
| 7 | ABPO |
Abpro Holdings, Inc.
|
358,427 | $0 |
All Filings in IMNM
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $214,800 | 10,000 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||